Altimmune (ALT) Begins Phase II Study for Chronic Hepatitis B
Altimmune, Inc. ALT announced that it has enrolled the first patient in a phase II study evaluating its novel peptide-based immunotherapeutic, HepTcell, for the treatment of chronic hepatitis B (“CHB”), a serious liver infection. Share more...
Westport (WPRT) Rides on Eco-Friendly Product Mix Amid Headwinds
Westport Fuel Systems ’ WPRT shares have rallied 231.3% quarter to date, outperforming the industry ’s rally of 31.1%. The company, which was renamed after the merger of Westport Innovations with Fuel Systems Solutions, has more...
American Manganese Reviews 2020 Highlights
Advances in Battery Recycling, Manganese Processing, and Gold-Copper-Rare Earth Spin-out AMY Progresses U.S. Department of Energy/Critical Materials Institute Project; Receives U.S. Department of Defense Grant and Canadian Government Funding SURREY, BC / ACCESSWIRE / December more...
Azarga Closes $6 Million Bought Deal Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / more...
Arcturus (ARCT) to Develop ARCT-032 for Cystic Fibrosis
Arcturus Therapeutics Holdings Inc. ARCT announced that it has selected ARCT-032 as a development candidate for Cystic Fibrosis (CF), which is a progressive hereditary disease. ARCT-032, based on the company’s proprietary LUNAR technology, is designed more...
TransEnterix (TRXC) Looks Good: Stock Adds 7.9% in Session
TransEnterix, Inc. TRXC was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than more...
T2 Biosystems (TTOO) Jumps: Stock Rises 8.7%
T2 Biosystems, Inc. TTOO was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands more...
Conformis, Inc. to Participate in Upcoming Investor Conferences
BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial more...
The Flowr Corporation Announces Interest Payment on Debentures
TORONTO, Dec. 31, 2020 (GLOBE NEWSWIRE) — The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“ Flowr ” or the “ Company ”) announces that it intends to satisfy the interest obligations in respect of its more...
Renren Announces Unaudited First Half 2020 Financial Results
Renren Announces Unaudited First Half 2020 Financial Results PR Newswire BEIJING , Dec. 30, 2020 /PRNewswire/ — Renren Inc. (NYSE: RENN) (“Renren” or the “Company”), which operates a premium used auto business in China through more...